StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · PRVA·Healthcare

Privia Health Group, Inc. Stock Analysis & AI Score

Privia Health Group, Inc. (PRVA) has an ST Score of 57.6 (B-), driven by its Sentiment (A+) and held back by its Momentum (D+). Analysts rate it Buy with a $27.33 price target (+40.9% upside).

Market Closed
$19.39
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
58
ST Score
57.6/100B-

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

PRVA
57.6out of 100
Grade B-

Privia Health Group, Inc. (PRVA) has an ST Score of 57.6 (B-), driven by its Sentiment (A+) and held back by its Momentum (D+). Analysts rate it Buy with a $27.33 price target (+40.9% upside).

Strongest
SentimentA+
Weakest
MomentumD+
All factor grades
  • SentimentA+
  • Financial StrengthB+
  • GrowthB+
  • ProfitabilityB
  • ForecastB
  • ValuationC+
  • MomentumD+
  • Piotroski2/9
Score methodology
Press Releases

Contact

PRVA stock: frequently asked questions

What is PRVA's ST Score?

Privia Health Group, Inc. (PRVA) has an ST Score of 57.6 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is PRVA a buy, hold, or sell?

Analysts rate PRVA a Buy, with a price target of $27.33 (+40.9% vs the current price). Our ST Score grades it B- (57.6/100). The ST Score is a data-driven signal, not a recommendation.

What are PRVA's factor grades?

Valuation C+, Profitability B, Financial Strength B+, Momentum D+, Growth B+, Forecast B, Sentiment A+.

What is PRVA's valuation grade?

Privia Health Group, Inc. (PRVA) earns a valuation grade of C+, measured against Medical - Healthcare Information Services peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is PRVA's growth grade?

Privia Health Group, Inc. (PRVA) earns a growth grade of B+, measured against Medical - Healthcare Information Services peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is PRVA's profitability grade?

Privia Health Group, Inc. (PRVA) earns a profitability grade of B, measured against Medical - Healthcare Information Services peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is PRVA's financial strength grade?

Privia Health Group, Inc. (PRVA) earns a financial strength grade of B+, measured against Medical - Healthcare Information Services peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for PRVA?

The average analyst price target for Privia Health Group, Inc. (PRVA) is $27.33 from 22 analysts, which is +40.9% versus the recent price of $19.39.

What is PRVA's Piotroski score?

Privia Health Group, Inc. (PRVA) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.